Chemical Structure : FR 180204
CAS No.: 865362-74-9
Catalog No.: PC-42937Not For Human Use, Lab Use Only.
FR 180204 is a potent, selective, ATP-competitive ERK inhibitor with Ki of 0.31 and 0.14 uM for ERK1 and ERK2, respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $85 | In stock | |
10 mg | $125 | In stock | |
25 mg | $195 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
FR 180204 is a potent, selective, ATP-competitive ERK inhibitor with Ki of 0.31 and 0.14 uM for ERK1 and ERK2, respectively.
FR 180204 inhibits TGFβ-induced luciferase-expression in mink lung epithelial Mv1Lu cells.
FR 180204 decreases plasma anti-CII antibody levels and attenuates delayed-type hypersensitivity in CII-immunized DBA/1 mice, also inhibits in vitro CII-induced proliferation of lymph node cells prepared from CII-immunized mice.
FR 180204 enhances apoptotic and anti-proliferative effects of Akt inhibitor API-1 in human DLD-1 and LoVo colorectal cancer cells.
M.Wt | 327.3427 | |
Formula | C18H13N7 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
DMSO: ≥ 50 mg/mL |
|
Chemical Name/SMILES |
1H-Pyrazolo[3,4-c]pyridazin-3-amine, 5-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)- |
1. Ohori M, et al. Biochem Biophys Res Commun. 2005 Oct 14;336(1):357-63.
2. Ohori M, et al. Naunyn Schmiedebergs Arch Pharmacol.
3. Chen-Roetling J, et al. Neuropharmacology. 2009 Apr;56(5):922-8.
4. Saglam AS, et al. Oncol Lett. 2016 Oct;12(4):2463-2474.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright